Speaker Profile
M.D., Ph.D., CEO, jscreen
Biography
Dr. Matt Goldstein is a dedicated physician-scientist and entrepreneur with a passion for advancing genetic research. As CEO of jscreen, he focuses on providing accessible, life-saving genetic testing to empower individuals with critical health insights. With extensive experience in biotech, Dr. Goldstein has led major initiatives, including founding and guiding companies like Tango Therapeutics and Neon Therapeutics through pivotal clinical developments and strategic partnerships. A graduate of Stanford University's MD/PhD program, he completed his clinical training at Harvard Medical School. Driven by both professional and personal experiences, including the loss of his eldest daughter, Havi, to Tay-Sachs disease, Dr. Goldstein is deeply committed to jscreen's mission of proactive health management.
Talk
Preventive Genetics: Life Inside the Punnett Square
A physician’s personal journey through love, devastating genetic misdiagnosis, and loss becomes a call to action for precision medicine. This talk explores the human cost of preventable genetic disease, the transformative power of accurate screening and IVF with PGT, and why prevention is one of medicine’s most profound moral imperatives.
Clinical Dx Showcase:
jscreen
jscreen.org is a national non-profit making preventive genetic testing and genetic care navigation affordable, accessible and actionable for everyone in the US.
Session Abstract – PMWC 2026 Silicon Valley
The PMWC 2026 Data Applications in Clinical Diagnostics Showcase will provide a 15-30 minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
